Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of mycophenolate mofetil in noninfectious uveitis and scleritis
jRCTs061220030Completed
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mycophenolate mofetil in uveitis, scleritis, Behçet's disease (BD) and 4 more. Primary endpoint: Safety. Started Aug 2022; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
uveitisscleritisBehçet's disease (BD)Multifocal chorioretinitis (MFC)retinal vasculitis (RV)
Beyond the preview
Go deeper on jRCTs061220030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220030.